DE60035107D1 - Spleiss-varianten des lim mineralisierungsproteins - Google Patents

Spleiss-varianten des lim mineralisierungsproteins

Info

Publication number
DE60035107D1
DE60035107D1 DE60035107T DE60035107T DE60035107D1 DE 60035107 D1 DE60035107 D1 DE 60035107D1 DE 60035107 T DE60035107 T DE 60035107T DE 60035107 T DE60035107 T DE 60035107T DE 60035107 D1 DE60035107 D1 DE 60035107D1
Authority
DE
Germany
Prior art keywords
lim mineralization
mineralization protein
nucleic acid
isolated nucleic
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60035107T
Other languages
English (en)
Other versions
DE60035107T2 (de
Inventor
Scott D Boden
Gregory A Hair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Application granted granted Critical
Publication of DE60035107D1 publication Critical patent/DE60035107D1/de
Publication of DE60035107T2 publication Critical patent/DE60035107T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60035107T 1999-04-30 2000-04-28 Spleiss-varianten des lim mineralisierungsproteins Expired - Fee Related DE60035107T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13202199P 1999-04-30 1999-04-30
US132021P 1999-04-30
PCT/US2000/011664 WO2000066178A1 (en) 1999-04-30 2000-04-28 Lim mineralization protein splice variants

Publications (2)

Publication Number Publication Date
DE60035107D1 true DE60035107D1 (de) 2007-07-19
DE60035107T2 DE60035107T2 (de) 2007-09-27

Family

ID=22452079

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60035107T Expired - Fee Related DE60035107T2 (de) 1999-04-30 2000-04-28 Spleiss-varianten des lim mineralisierungsproteins

Country Status (13)

Country Link
US (2) US7045614B1 (de)
EP (2) EP1808182A1 (de)
JP (1) JP4615736B2 (de)
KR (1) KR100697403B1 (de)
CN (2) CN1315537C (de)
AT (1) ATE363918T1 (de)
AU (1) AU765516B2 (de)
CA (1) CA2372192A1 (de)
DE (1) DE60035107T2 (de)
ES (1) ES2288474T3 (de)
HK (1) HK1045939B (de)
NZ (1) NZ515584A (de)
WO (1) WO2000066178A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7741117B2 (en) * 1997-04-30 2010-06-22 Emory University Bone mineralization protein expression systems, and methods of studying intracellular signaling pathways induced thereby
US6300127B1 (en) * 1997-07-30 2001-10-09 Emory University Bone mineralization proteins, DNA, vectors, expression systems
US7923250B2 (en) * 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
US20030225021A1 (en) * 2001-11-14 2003-12-04 Mckay William F. Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta proteins (TGF-betas) in cells
US8916691B2 (en) * 1998-07-29 2014-12-23 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein
US6811776B2 (en) 2000-12-27 2004-11-02 The Regents Of The University Of Michigan Process for ex vivo formation of mammalian bone and uses thereof
AU2466601A (en) * 1999-12-28 2001-07-09 Regents Of The University Of Michigan, The Process for ex vivo formation of mammalian bone and uses thereof
JP2004536794A (ja) * 2001-04-09 2004-12-09 メドトロニック、インコーポレイテッド マイクロ遠心機を用いる血液成分の分離方法及びその使用法
US7781574B2 (en) * 2001-11-14 2010-08-24 Emory University Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof
AU2004317501B2 (en) * 2004-04-13 2011-09-01 Emory University Intracellular delivery of osteoinductive proteins and peptides
EP1896046A2 (de) * 2005-03-22 2008-03-12 Warsaw Orthopedic, Inc. Mechanismen der osteoinduktion durch das lim mineralization protein-1 (lmp-1)
WO2008156500A2 (en) * 2006-11-21 2008-12-24 Warsaw Orthopedic, Inc. Methods of inducing or increasing the expression of proteoglycans such as aggrecan in cells
US20090110637A1 (en) * 2007-10-26 2009-04-30 Warsaw Orthopedic, Inc. LMP and Regulation of Tissue Growth
BR112012017535A2 (pt) 2010-01-15 2019-09-24 Of Medicine And Dentistry Of New Jersey University uso de compostos de vanádio para cicatrização de osso
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
WO2013006798A1 (en) 2011-07-06 2013-01-10 University Of Medicine And Dentistry Of New Jersey Vandium compounds as therapeutic adjuncts for cartilage regeneration and repair
CA2827392A1 (en) 2011-02-24 2012-08-30 Emory University Noggin blocking compositions for ossification and methods related thereto
US20140248372A1 (en) 2011-09-19 2014-09-04 Emory University Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
CA3127015A1 (en) * 2011-11-29 2013-06-06 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
WO2014011540A1 (en) 2012-07-09 2014-01-16 Emory University Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300127B1 (en) * 1997-07-30 2001-10-09 Emory University Bone mineralization proteins, DNA, vectors, expression systems

Also Published As

Publication number Publication date
CN1315537C (zh) 2007-05-16
US20070116689A1 (en) 2007-05-24
NZ515584A (en) 2005-03-24
US7045614B1 (en) 2006-05-16
EP1808182A1 (de) 2007-07-18
CN1355714A (zh) 2002-06-26
US7517866B2 (en) 2009-04-14
WO2000066178A1 (en) 2000-11-09
EP1181056A4 (de) 2003-04-16
DE60035107T2 (de) 2007-09-27
HK1045939B (zh) 2007-10-05
JP4615736B2 (ja) 2011-01-19
KR20020033615A (ko) 2002-05-07
AU4683100A (en) 2000-11-17
ATE363918T1 (de) 2007-06-15
CN1908170A (zh) 2007-02-07
WO2000066178A9 (en) 2001-03-15
KR100697403B1 (ko) 2007-03-20
CN100441688C (zh) 2008-12-10
HK1045939A1 (en) 2002-12-20
EP1181056A1 (de) 2002-02-27
AU765516B2 (en) 2003-09-18
EP1181056B1 (de) 2007-06-06
ES2288474T3 (es) 2008-01-16
CA2372192A1 (en) 2000-11-09
JP2002542802A (ja) 2002-12-17

Similar Documents

Publication Publication Date Title
ATE417927T1 (de) Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme
DE60035107D1 (de) Spleiss-varianten des lim mineralisierungsproteins
Nomura Bacterial ribosome
ATE443074T1 (de) Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren
ES2177475T1 (es) Genes de corynebacterium glutamicum que codifican proteinas de una ruta metabolica.
AP1678A (en) Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems.
DK0973928T3 (da) DNA-baseret transposonsystem til indføring af nukleinsyre i DNA i en celle
WO2001000844A3 (en) Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
ATE315087T1 (de) Neuartige auf p53 ansprechende gene
EP1798239A3 (de) G-Protein-gekoppelte Rezeptoren und deren Verwendung
BR9809433A (pt) Moléculas de dna enzimáticas
DK0489058T3 (da) Cystisk fibrose gen
HUP0203340A2 (hu) Stressz-, rezisztencia- és toleranciafehérjéket kódoló Corynebacterium glutamicum gének
DE60035517D1 (de) Gl50 moleküle, sowie verwendungen derselben
WO2001000842A3 (en) Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
WO2003042368A3 (en) Methods of expressing lim mineralization protein in non-osseous cells
AU2390301A (en) Corynebacterium glutamicum genes encoding metabolic pathway proteins
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
WO2005023996A3 (en) METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS
WO2002066636A3 (en) T cell receptor variants expressed in mesenchymal cells and uses thereof
DE60137222D1 (de) Humanes trp-ähnliches kalziumkanalprotein-2 tlcc-2
WO2001053470A3 (en) Nucleic acid and amino acid sequences encoding a de novo dna methyltransferase
JP2006280261A (ja) 細胞内へ核酸を導入する為の新規な分子並びに細胞内へ導入する核酸および細胞内へ核酸を導入する為の新規な方法
DE60124910D1 (de) Menschliche twik-8 moleküle und ihre verwendung
AR123483A1 (es) Enzimas modificadoras de adn y fragmentos activos y variantes de las mismas y métodos de uso

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee